i3 Pharmaceuticals, LLC specializes in the development, manufacturing, and supply of complex solid oral generic products. The company is committed to producing high-quality specialty pharmaceuticals that enhance patient affordability and confidence in their therapies. Their expertise lies in formulating technically challenging products, including sustained release formulations, poorly soluble drugs, and unstable molecules. The company operates a state-of-the-art facility in Warminster, PA, which was significantly upgraded after its acquisition in 2015, allowing for efficient product development, manufacturing, packaging, and testing.

The company emphasizes its technical capabilities, particularly in handling low-occupational exposure limit products and addressing challenges related to solubility and stability. i3 Pharmaceuticals employs a highly experienced team that supports the entire lifecycle of product development, from concept to commercial supplies. Their quality systems are designed to meet stringent FDA and regulatory standards, ensuring that all processes are compliant and well-documented. This focus on quality and innovation positions i3 Pharmaceuticals as a reliable partner in the pharmaceutical industry, dedicated to delivering effective and affordable medication options.

United States

i3 Pharmaceuticals' mission is to develop, manufacture and bring to market high-quality, difficult to formulate, high technological barrier solid oral specialty pharmaceutical products.

As a company, i3 Pharmaceuticals' drive for excellence arises from the company's core values:
Insight into markets and products,
Ingenuity in product selection and development, and
Integrity in our partnerships, with an uncompromising dedication to product quality.

i3 Pharmaceuticals, LLC

Company Details